CDH2 and breast carcinoma: This downregulation of OPG in breast cancer cells was accompanied with an increase in the expression of the ERα protein and the epithelial markers E-cadherin and EpCAM, while the mesenchymal markers N-cadherin, Snail, and ZEB1 were downregulated (Fig. 7A).